Climate-linked migration and displacement affect health in multiple pathways. A new WHO research initiative in the Western Pacific Region aims to find out more.

WHO’s Western Pacific region, the agency’s most populous, is home to nearly two billion people, including some small island nations like Fiji, Tuvalu and the Marshall Islands whose very existence is threatened by climate change.

And yet, no one really knows how many people are on the move due to climate-related extreme weather events that are eroding coastlines, encroaching on communities and curbing traditional economic activities, triggering displacement and migration in small island states and beyond.

To address such gaps, the World Health Organization’s Western Pacific Regional Office recently launched a research agenda asking countries in the region to track such movements, amongst a host of other climate-related health risks.

Central to the initiative is the understanding that climate change, migration or displacement and health are intrinsically linked, said Sandro Demaio, Director of the WHO’s Asia-Pacific Centre for Environment and Health (ACE), in a webinar launching the initiative on Monday.

“Despite the growing recognition that these interconnected issues exist and are playing out in real time, important knowledge gaps remain. We still need a better understanding, more clarity, more commitment, more depth of how climate change influences patterns of migration and displacement, and how these dynamics affect health outcomes,” Demaio said.

The agenda is meant to push countries to create sound evidence, allocate finances and design effective interventions as they draft their national climate and health policies.

In focus: Western Pacific and Asia region


Currently, most studies come from high-income settings. Apart from that, “limited evidence exists on anxiety, trauma, depression, and resilience among people displaced by climate-related events,” said Dr Santino Severoni, Director of the Health and Migration Programme at WHO, Geneva.

“More research is needed on children, older adults, pregnant women, people with disabilities, and Indigenous communities affected by climate,” he added.

Push to focus on health of migrant and displaced populations

WHO has released a health and migration research roadmap for the countries in the Western Pacific region.

Recognizing that the Western Pacific region is a large one, WHO has tweaked the agenda to make it more tailored to the Pacific as well as the Asia sub-regions, respectively.

For the Pacific region, the WHO has asked countries to focus on research on cultural loss as the small-island states battle for their survival.

“In the Asian sub-region, the report flags visa status and labor exploitation as major under-research commercial determinants,” said Brian Hall, Director of the Center for Global Health Equity, NYU Shanghai.

Also read: As El Niño Intensifies – WMO Warns Policymakers to Brace for Escalating Impacts on Health Worldwide

Health of migrants central to delivering universal healthcare

WHO has released a health and migration research roadmap for the countries in the Western Pacific region.

Within migrant communities, as well, there are particularly vulnerable sub-groups, including entirely stateless populations, as well as women, children and older people, who may be disproportionately hit.

“Most countries don’t disaggregate health data by migration status, so we’re flying blind on maternal and child health, immunization, and chronic disease in micro populations,” Hall said.

A key WHO ask of the countries is that they also empower communities to lead the research.

“First and foremost, involve the communities from the beginning when the research questions are defined, not only during the data collection. Second, I would say recognize the lived experience of young people as their expertise, because young people in communities on the move should help shape the evidence and inform the policy priorities,” said Salsabila Rashid, youth representative of the New York – based civil society group, Migration Youth and Children Platform.

Image Credits: WHO/Yoshi Shimizu, WHO, WHO.

The World Health Assembly plenary where the historic Pandemic Agreement was approved. It cannot come into effect until the PABS annex is agreed.

The Pandemic Agreement talks resumed at the World Health Organization’s (WHO) headquarters on Monday, kicking off with a public “debriefing” summarising the incremental progress made during informal talks conducted over May and June, followed by a closed session on existing models for sharing data on pathogens with pandemic potential.

Speaking at the opening of the session, WHO Director Dr Tedros Adhanom Ghebreyesus urged member states to keep two simple end goals in sight. Those include: “A future in which pathogen samples and information move quickly, without needless delay; and in which the benefits that come from them reach the people who need them most, fairly and in time.

“The differences that remain are real. They matter to the people you represent, and I respect that,” Tedros added. “But they are not impossible to bridge. So I ask you: focus on what truly matters. Don’t let the urgency fade.”

Detailed summary presented at the resumed PABS negotiations Monday reflects slow, but incremental progress on the many outstanding technical issues.

While those close to the talks confirm that slow progress is being made, this 10-day negotiating session (which ends 17 July) is unlikely to result in an agreed pathogen access and benefit-sharing (PABS) system just yet.

Wide differences remain with regards to how a standardized system for both pathogen registration and eventual benefit-sharing of R&D products could be created and enforced, in light of the multiple approaches being used in reality today.  Those differences – as well as potential bridging solutions – were vividly on display again Monday as member states and observers shared their experiences.

Pathoplexus, the database where the gene sequence for the Ebola Bundibugyo virus was first shared, pointed to the staged data-sharing approach to used by the Uganda-led team that first sequenced the pathogen as an example of a hybrid solution.

Pathoplexus representative addresses the PABS meeting Monday.

“They initially chose a time-limited restricted use option, making data fully open for public health analysis, phylogenetics, and output tools immediately, while protecting the right to publish first,” Pathoplexus noted. Then last week, following publication in a scientific journal, the same data was released “to fully open status,” he said.

“Our current model does not yet solve the question of access and benefit from commercial use, but that question matters urgently. The rapid development of vaccines, diagnostics, and treatments is crucial for outbreak response, and should be facilitated by clear, standardized, and agreed terms,” the Pathoplexus representative stated.

Meanwhile, the South Centre expressed skepticism about a PABS agreement that might embrace too much diversity to pathogen registration and sharing.

“We do have some concerns with some ideas about hybrid approaches,” the delegate stated. “We think that the standardization of the of the way the design of the PABS system is done is essential. Otherwise, this will create other uncertainties and more difficulties, in particular with the reference to what obligations member states will take. We think it’s essential that … the whole system is built on the basis of standard contracts, also to ensure what are the means that member states themselves can, through their own legislatures, support that contractual structure.

“We see that there has been the clear textual line on access stating an obligation for member states to facilitate rapid access. At the same time, you can have provisions domestically to facilitate benefit sharing …..ensuring that benefit sharing from any commercial use requires this payment to the system that goes to the multilateral tax fund. ”

Linkage or not ?

Pharma leaders, meanwhile, stressed that any pathogen sharing system should be “grounded in outbreak reality”  and aim to “reduce rather than increase both legal uncertainty and the restrictions that could delay scientists’ ability to access and use pathogen data.

“We share the objective of ensuring equitable access to medical countermeasures and companies have demonstrated this commitment repeatedly through proactive and voluntary engagement across public health emergencies, including COVID-19, mpox, and Ebola,” said a representative for the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). “However, introducing a cumbersome PABS system will not improve preparedness or access outcomes. In practice, the main bottlenecks have consistently been related to financing, regulation, and delivery – not supply.

“Looking ahead, it is critical that we do not jeopardize the progress achieved in the Pandemic Agreement, including the set-aside mechanism, by introducing a PABS system that is impractical for research and potentially counterproductive. Instead, we should build on existing mechanisms that already enable rapid, open, and effective data sharing, including established international databases, while ensuring that countries are supported and enabled to operationalize agreed access provisions.”

Equity provisions triggered by product registration

Geneva representative, Thiru Balasubramanian delivers KEI’s proposal for two core paragraphs for the PABS annex at Monday’s meeting.

Finally, Knowledge Ecology International suggested that two simple paragraphs should form the core of the final PABS text – clearly committing states to enforce the medicines/vaccines access and equity provisions of the Pandemic Agreement – but without creating any direct linkage to the way pathogen data is accessed for R&D purposes.

“For some time, KEI has taken the position that equity provisions should not be linked to access to PABS materials or data, that governments joining the treaty should be responsible for enforcing the access/equity provisions, and that those provisions should be triggered by the registration and sale of products, not access to information,” said James Love, head of KEI, in a statement on Sunday.

“This is how we suggest it be done, in two short paragraphs,” he added, setting out the first paragraph of the Annex as stating that:

“Each party [to the agreement] shall take all necessary legal, administrative, or regulatory measures to ensure that any manufacturer seeking to register or sell pandemic-related products within its jurisdiction provides verifiable evidence of a legally binding agreement with the World Health Organization (WHO) that addresses access to such products, consistent with Article 12, Paragraph 6, of the Pandemic Agreement.”

Article 12, paragraph 6  stipulates that manufacturers must make available a minimum oof 20% of their real time pandemic production to WHO, half of that as a donation and the other half at “affordable prices.”

A second paragraph in the proposed KEI text would stipulate that the obligations set forth under the PABS Annex apply “exclusively” to products produced to address the public health emergency and “not extend to other uses or indications of the same products,” Love said.

Africa aims to level the playing field

Malawi’s Health Minister Madalitso Baloyi at the UN High Level meeting on HIV/AIDS in June.

It remains to be seen how African nations will respond to the new ideas being tabled as it seeks to assert itself in the PABS negotiations and ensure that citizens of its 54 countries have better access to medicines, vaccines and diagnostics.

At the recent United Nations High-Level Meeting on HIV/AIDS, the African group negotiated as a bloc – bar a handful of countries – and insisted on the inclusion of several paragraphs to encourage wider access to medicines, including local production, technology transfer and reward for innovation. Several Latin American countries also supported this position.

Africa also insisted on a last-minute amendment to the political declaration on HIV, proposing the removal of the phrase “mutually-agreed terms” in relation to technology transfer in three paragraphs of the 15-page declaration. 

“The African group believes that keeping ‘on mutually agreed terms’ in the text, in connection to technology transfer, undermines the key objective to access medicines, vaccines, and medical products, and to boost research and development,” said Malawian Health Minister Madalitso Baloyi on behalf of the Africa Group.

While the political declaration passed, the European Union (EU), Switzerland, Canada and several other countries dissociated themselves from these paragraphs.

Switzerland said that technology transfer should “always be on mutually agreed terms”.

It also objected to a paragraph (85) that committed countries to improving the transparency of markets for HIV-related health technologies, by “publicising production costs and prices of HIV-related products, through global, regional and national mechanisms, thus providing consistent and transparent information for fair price negotiations”.

“There are limits anchored in relevant international law to publicising information, such as production cost. Paragraph 85 raises concern regarding the protection of trade secrets, and more fundamentally, what role of state authorities can be in relation to private sector actors,” said Switzerland.

‘No country alone can fight’

Meanwhile, Tedros and other WHO officials have urged member states to hasten agreement of the PABS system, particularly in light of the recent string of dangerous disease outbreaks, including the Ebola Bundibugyo virus public health emergency declaration.  

“The outbreaks of hantavirus, Ebola and Marburg all show why there is no alternative to international cooperation in the face of international threats. No country alone can fight,” Tedros told a media briefing last week.

The outbreaks are that the risk of another pandemic erupting is “not some distant, hypothetical scenario in a briefing document,” Tedros added in his statement on Monday.

WHO’s head of health emergencies, Dr Chikwe Ihekweazu, said that navigating several public health emergencies simultaneously was a trend which is likely to continue.

“The threats are not going away,” said Ihekweazu. “But hopefully we can get stronger collectively to respond to these.”

Several positive developments had evolved out of the recent threats, he added. These included countries improving their disease response detection and response capabilities,  R & D on new countermeasures, and opportunities for countries to work together under the International Health Regulations, the legally binding rules for country conduct during disease outbreaks.

But, stressed Ihekweazu, the PABS system “absolutely has to be completed” to enable the Pandemic Agreement to be ratified and brought into effect to establish a strong global framework to address disease outbreaks.  See related story: 

https://healthpolicy-watch.news/drc-ebola-outbreak-may-be-much-larger-than-currently-reported/

Image Credits: PABS IGWG7 Debriefing.

Two children engrossed in using their smartphones in a dimly lit setting. A lack of digital governance exposes young people to algorithmic harms and severe health risks, warn WHO and France.
A lack of digital governance exposes young people to algorithmic harms and severe health risks, warn WHO and France.

A lack of youth online safety is a global public health crisis that demands systemic platform regulation to protect children from harm, according to a joint declaration by the French government and the World Health Organization (WHO). They demand urgent digital governance to mandate safe platform redesigns, as nations struggle to enforce easily bypassed social media bans.

While online environments can offer educational and social benefits, poorly governed digital spaces pose grave risks to the physical and mental development of youth, French President Emmanuel Macron and WHO Director-General Dr Tedros Adhanom Ghebreyesus said in the statement released last week. They warn that features including infinite scrolling, autoplay, and push notifications increase the risk of addictive behaviour.

“Our children and young people are not experimental subjects, a captive market, or a commodity,” they asserted.

Calls for ‘pro-child’ digital governance

Macron and Tedros at the One Health Summit in Lyon this year. They demand urgent digital governance.
Global leaders Macron and Tedros push for ‘pro-child’ digital platform regulation.

The leaders warn that unregulated digital marketing exposes vulnerable adolescents to harmful products, echoing public health advocates who accuse the tobacco, alcohol and sugary drink industries of flooding social media to evade advertising regulations.

Furthermore, Macron and Tedros note that, despite its opportunities, generative artificial intelligence acts as a force multiplier for major risks facing youth online, with its long-term impact on children’s emotional development, including their ability to form real life relationships and capacity for empathy, remaining uncertain.

They advocate for a precautionary approach to digital platform design, insisting that such measures are “pro-child” rather than anti-innovation, emphasising that preventing exposure to illegal, extreme, and graphic content is a public health imperative.

Governments and the technology industry must implement transparent data sharing, age-appropriate design, and stronger safety-by-design standards. To enforce these safety standards across the board, the joint mandate calls for independent, longitudinal research and strict corporate accountability.

Legal battles and industry pushback

This push for comprehensive digital governance comes as legal and regulatory pressure against social media platforms is mounting. Recent court rulings in the United States have included a $375 million judgment against Meta in New Mexico and European Union investigations under the Digital Services Act. They have targeted platforms like YouTube and TikTok for designing addictive products.

Technology giants reject allegations that they prioritise engagement over safety, and argue they actively protect younger users. Meta points to its ‘Teen Accounts’ which automatically limit content and contact for under-16s, while TikTok promotes over 50 preset teen safety features.

However, independent researchers argue that existing corporate safeguards fail to address the root problem. They note that technology companies restrict independent data access while continuing to deploy algorithmic features explicitly designed to manipulate the developing brain’s reward systems.

The national ban dilemma

Meanwhile, political efforts to exclude children entirely from social media, like the world’s first national ban for children under 16 in Australia, are facing severe enforcement setbacks.

Early evidence published in the British Medical Journal (BMJ) reveals that over 85% of teenagers easily bypass the restrictions by retaining existing unverified accounts, using fake birthdays, or borrowing devices from parents and older siblings. Daily screen time remains unchanged at up to four hours.

While Macron and Tedros view national age restrictions as a positive sign that governments recognise the public health crisis, they argue that true protection requires more than just the absence of harm. Children’s wellbeing depends on safe digital infrastructure that actively supports healthy development rather than disrupting it.

Big Tobacco is No Longer Selling Cigarettes – It Is Engineering Addiction

Image Credits: Ron Lach via Pexels, WHO / Laurent Cipriani .

El Niño conditions are set to intensify in the July-September, bringing extreme weather conditions to significant parts of the world.

The El Niño conditions that bring extreme rainfall, heat waves and drought to different parts of the world are set to intensify further during the July-September period this year, said the World Meteorological Organization (WMO).

While the Indian subcontinent has to brace for below-normal rainfall, parts of Africa and southern Europe will see above-normal rainfall, according to WMO’s latest update, published Friday.

“El Niño conditions are already underway and are forecast to strengthen rapidly into a strong event – as accurately anticipated by WMO forecasts. This will intensify the chances of drought and heavy rainfall and the risk of heatwaves on land and marine heatwaves in many regions of the world,” said WMO Secretary-General Celeste Saulo.

Both drought and flooding pose big threats to food production in already food insecure parts of the world, while heavy rains that cause flooding create displacement and exacerbate outbreaks of infectious and water-borne diseases such as cholera. Extreme heat, too, exerts mounting pressure on food production, Qu Dongyu, Director-General of UN’s Food and Agriculture Organization has warned.

Europe already reeling from heatwave

Over 1,300 people have died of heatwave in Europe this summer.

The warning comes as large parts of Europe were already reeling under a heatwave that has led to over 1300 deaths.

“It’s the first week of July, it’s the start of what is traditionally the hottest month of the year,” WMO spokesperson Clare Nullis told journalists in Geneva. “And yet already in June we’ve seen record-breaking temperatures in many parts of Europe; just as an example, Germany last weekend saw a new national temperature record of 41.7°C.

The WMO had already warned of El Niño conditions developing in the agency’s June update. Now conditions have further escalated.

See related story here:

El Niño Conditions Will Lead to More Heatwaves, Droughts and Wildfires Over Next Few Months, Warns WMO

What is El Niño

 

El Niño causes the Pacific jet stream to move south and spread further east. During winter, this leads to wetter conditions than usual in the Southern U.S. and warmer and drier conditions in the North.

While a natural phenomenon, more extreme El Niño conditions are a result of the warming of ocean temperatures in the Pacific that affect the wind-patterns in turn.

Normally, strong east-to-west trade winds push warm surface water toward Asia and Australia, allowing cold, nutrient-rich water to build up along the coast of South America.

During an El Niño event, however, warmer-than-average sea surface temperatures and weakened trade winds push warmer water eastward toward the Americas, shifting global weather patterns.

This year the sea-surface temperatures are over 2°C higher than what is typical in several key monitoring areas.

Below normal rainfall in the Indian Subcontinent and above normal in parts of Africa

Multi-model ensemble forecasts from leading global producing centres for the central and eastern equatorial Pacific.

It is therefore likely that the Indian subcontinent and much of Australia will receive below-normal rainfall, while above-normal rainfall is forecasted for the central and eastern equatorial Pacific region.

In west Africa, the Ivory Coast, Ghana and other countries along the Atlantic Ocean’s Gulf of Guinea are projected to receive above-normal rainfall. But on the eastern side of the continent, below-normal rainfall is forecast for already food-insecure countries such as Eritrea, Ethiopia and Somalia along the Horn of Africa coast of the Indian Ocean.

Below-normal rainfall is also forecast for parts of Central America, the Caribbean and northwestern South America. In contrast, wetter-than-average conditions are more likely across portions of the southwestern United States.

Across Europe, forecasts suggest a north-south contrast, with increased chances of above-normal rainfall in southern Europe and below-normal rainfall in northern Europe. However, for Europe, forecast confidence remains lower than in many other regions.

WMO helping countries brace for impact

Celeste Saulo, WMO Secretary-General

WMO said it has begun intensifying its mobilization of information and support services so that countries can brace for the impacts of El Niño.

Regular briefings are being provided across the United Nations system and to humanitarian partners to support preparedness.

“The WMO community has launched an unprecedented mobilization to coordinate activities across the United Nations and at regional level to support governments, humanitarian organizations and climate-sensitive sectors,” Saulo said. “Advanced seasonal forecasts and early warnings are vital to save lives and cushion the impact on our economies and our communities.”

Image Credits: Dikaseva/ Unsplash, WHO / Hedinn Halldorsson, NOAA, WMO.

Leslie Ransammy, Guyana’s Ambassador to the UN in Geneva at a high level event on sexual and reproductive health rights in Geneva in May.

The dramatic global health budget cutbacks in services for maternal and reproductive health and sexually transmitted infections (STIs) have produced 17 million unintended pregnancies, and more than 34,000 preventable maternal deaths in just the first year since cuts were made. 

That recent assessment by French and Washington DC-based analyses, was cited by Guyana’s UN Ambassador in Geneva, Leslie Ramsammy, at a World Health Assembly side event in May. 

And with deep, ongoing cuts in United Kingdom and European global aid budgets, as well as an anti-family planning and anti-choice mood in the US and many African countries, access to services may only worsen – along with the death toll. 

Just last week, eight UN member states, including the United States, Russia and several African nations, and another 14 countries, mostly Middle Eastern, abstained from a vote on the 2026 UN High Level Political Declaration on HIV/AIDs – largely because it reaffirmed sexual and reproductive health rights.  At the last WHA, meanwhile, SRHR captured little space on the formal agenda. 

Against the threats, inspiring models of progress

Guyana’s first lady Arya Ali launches a menstrual hygiene initiative in one of the country’s remote regions in June 2025.

But against the threats and setbacks, there are also inspiring models of progress in low-and middle income countries such as Barbados, Guyana and Malawi, offer models that deserve wider attention, Ramsammy said. 

Processes like the Human Rights Council’s Universal Periodic Review (UPR) can also be harnessed to accelerate progress, Ramsammy and other members of the high level panel convened by the Global Center for Health Diplomacy and Inclusion (CeHDI), also emphasized. 

“Let me urge that we refrain from viewing SRH strictly and merely as a health issue,” Ramsammy said. “Providing voluntary access to contraception and a safe birth environment is not just a medical necessity, it is economic and social capital. 

“Investing in SRHR reduces poverty, bolsters gender equality, and fosters resilience to global crises. 

“When girls and women have the autonomy to make decisions about their own bodies, they are more likely to pursue education, participate in the workforce, and act as equal partners in their relationships. 

Barbados, Guyana and Malawi offer models for Africa and the Caribbean  

Lisa Cummins, Minister of Health, Barbados

Barbados’ progressive SRHR landscape, for instance, includes legal abortion and access to reproductive health services – most delivered free of cost through its primary health care budget, said Lisa Cummins at the CeHDI event. Cummins is also the country’s first female Minister of Health since the 1990s.  

The quality of services is reflected in Barbados’ low maternal mortality rates and high uptake of  HPV vaccine, which prevents cervical cancer.

At the same time, the country is facing challenges in declining donor support for civil society groups that work closely with the government to deliver SRHR services, particularly the Barbados Family Planning Association (BFPA) – as a result of anti-rights activism abroad.

“That is part of a global conversation on external partners attempting to police our bodies – and to determine what we should and should not have access to as women,” Cummins said.  

Expanding SRHR services despite donor cutbacks

Mia Mottley, Prime Minister Barbados, at the UN General Assembly in 2025. She is a global advocate for gender equality, as well as climate sustainability and debt relief.

 But the current government remains committed to maintaining and expanding SRHR services, she asserted. 

“I’m not sure if you’ve ever met my leader,” she quipped, referring to Barbados Prime Minister Mia Mottley, a Global South champion for gender equality as well as for economic and climate justice.  

“But [she] and the first Prime Minister of Barbados, the Honourable Errol Barrow, said something that we all live by – and that is ‘friends of all, satellites of none.’ ”  

So even as outside funding has diminished, the BFPA has broadened services through closer cooperation with the public health system, integrating HIV counseling, maternal counseling, family planning and parental support so “we’re able to support parents in being better parents.”

“We believe in the protection of rights for women and girls. We believe in the preservation of the rights that have been established under the UN system and have been promoted by UNFPA. And we are committed to continuing to support the preservation of these rights,” said Cummins, adding, “That is who we are.”

Harnessing the Human Rights Council’s Universal Periodic Review (UPR) 

The Human Rights Council’s Universal Periodic Review (UPR) is a state-led mechanism that evaluates each country’s human rights obligations and commitments, including the right to health.

One often-overlooked but powerful multilateral lever is the Human Rights Council’s Universal Periodic Review (UPR) process, noted CeHDI’s CEO, Haileyesus Getahun. 

The UPR is a peer review  assessment every four or five years by HRC member states of progress in human-rights related legislation, policies and practices  – including obligations of governments to the right to health and public health measures. 

A recent analysis of the impacts of UPR recommendations across three review cycles (2005–2023) found the recommendations were associated with accelerated improvements in maternal health among high-burden countries.Critical SRHR indicators included in the analysis were maternal mortality rates (MMR), skilled birth attendance (SBA) and contraceptive prevalence (CPR).

Haileysus Getahun, CEO of the Global Center for Health Diplomacy and Inclusion (CeHDI).

Among the more than 400 recommendations assessed across 89 countries, each additional recommendation was associated with a 0.24% faster annual reduction in MMR, a 0.52% faster annual increase in odds of SBA and a 0.21% faster annual gain in CPR.  This is according to the preprint of a study published in June on medRxiv.org by five CeHDI and WHO analysts. 

“This is robust evidence showing that the UPR process is not a mere talk show. It can be an important accountability tool to advance universal health coverage including SRHR ” Getahun said.   

He attributes UPR’s influence to involvement of high-profile ministries like the Cabinet, Foreign Affairs or Justice — which often carry more domestic political clout than health ministries — and parallel assessments by UN agencies and national stakeholders: 

“So these are three independent processes, reviewing previous recommendations and the country’s performance in terms of all the rights where governments have obligations.” 

Malawi sees SRHR as a human right 

Madalitso Baloyi, Minister of Health and Sanitation, Malawi

Africa’s record on SRHR rights and services has been mixed: abortion remains outlawed in many countries and LGBTQI criminalization has limited access to services.

Malawi, however, has made notable progress. It has been a leader in sub‑Saharan Africa in expanding voluntary family planning and reducing teenage pregnancies through access to quality contraceptives.

But the country still struggles with high rates of maternal mortality, gender-based violence and restrictive abortion laws.

“Malawi, through the Ministry of Health, recognizes that sexual reproductive health as a human right as well as a health issue, and we take this issue seriously,” said Madalitso Baloyi, Minister of Health. “We treat SRHR as a current issue, but also an issue that has an effect on future generations.”

Barriers remain: they include limited infrastructure at primary-care level, weak referral and incomplete health information systems that lead to gaps between primary and secondary health tiers, and social stigma. 

With respect to stigma, Baloyi described the disparity in community response: neighbors may mobilize to transport a sick child, but survivors of rape are often left to find their own way to care. 

More joined up financing for SRHR and primary health care services 

A young girl receives a single dose of HPV vaccine at Lisawo primary school in Chiradzulu Malawi – a measure critical to reducing cervical cancer.

The government’s National Health Financing Strategy is prioritizing strengthening primary health care. Plans to introduce a National Health Insurance Scheme are also in the works. And the Ministry of Health aims to give local clinics more control over their own spending in line with local priorities and needs, she said.

“As government, we are looking at how to strengthen primary health care service provision, but the gaps are still there in terms of infrastructure,” she said. “The limited budget impacts quality of care, especially at primary level, while the distances that one travels just to get care is also an issue.” 

Paradoxically, donor cuts have pushed Malawi to increase domestic spending on maternal health by 10%, with knock-on benefits for SRHR, Baloyi said. 

“We are also integrating services — so the same young women who seek SRHR care also receive HIV prevention and treatment as needed. And that can reduce costs and improve outcomes. 

“There’s a silver lining to the ODA budget cuts,” she added. “It’s bad when the budget is shrinking, but it is also giving us, as government, power to deal with our own challenges, our own problems.”

New donor partnerships and targets 

reproductive health
Percilda Manhica, a nurse at Health Center in Manhica, consults a patient, Clara Obadias Matavele, 32, about family planning needs, at the Health Center in Manhica Village, Mozambique.

Panelists agreed that while donor funding may partially rebound, stronger national commitments and new kinds of partnerships are essential. 

“It’s a fact that we will have to confront less funding in the future, so we have to somehow establish a new kind of partnership,” said Germany’s Ambassador to the UN in Geneva, Antje Leendertse.

She proposed that bilateral donor commitments include concrete targets for allocation to women’s health. “Sexual and reproductive health and rights should not be treated as an add-on, one optional thing,” she said.

Antje Leendertse, Germany’s Ambassador to the UN in Geneva.

 “I think there should be some kind of agreement on a kind of goal – such and such percentage of every health engagement of a donor country or a community of donor countries has to flow into women’s health….That would be not only the right thing to do but also the smart thing to do.” She also urged prioritizing SRHR in humanitarian aid.

But such goals have been articulated in the past without achieving the desired effect, Ramsammy pointed out. 

While an informal benchmark of 10% for SRHR has been cited by international parliamentarians and advocacy groups, only 23% of donors allocated more than 5% of their ODA to SHRH, he noted. 

“So I think the call here is that we reiterate and strengthen that commitment,” Ramsammy added.   

“We need predictable financing to safeguard critical programs, including maternal health, family planning, and adolescent health, from growing political and funding pressures.” 

“We need to implement consistent high-quality sexuality education to equip young people with tools to prevent unintended pregnancies, sexually transmitted infections, and sexual coercion need to advance coordinated global and national action among governments, partners, and civil society to protect hard-won gains and ensure no woman, no birth is left behind in access to SRHR within universal health coverage.”

Image Credits: Dominic Chavez/World Bank, News Room , Health Policy Watch , WHO, 2019, Nadia Marini/MSF .

A young man who has been cured of Ebola Bundibundyo speaks to health workers in the DRC.

A trial to test two antiviral therapies on patients with Ebola Bundibugyo Virus started to enrol patients on Thursday – but its exact location in the Democratic Republic of Congo’s (DRC) Ituri province remains secret for security reasons.

This emerged at a World Health Organization (WHO) briefing on Thursday, at which Director General Dr Tedros Adhanom Ghebreyesus revealed yet another Ebola treatment centre in Ituri had been attacked in the past week.

Citing “mistrust and violence” as significant obstacles to addressing the Ebola outbreak, Tedros said that the attack had resulted in the deaths of two people, the centre being set on fire and patients fleeing.

The attack related to the burial of a community member who had died of Ebola, added Dr Chikwe Ihekweazu, WHO’s executive director of health emergencies.

There were 1,406 confirmed Ebola cases and 438 deaths by 30 June, a case fatality rate of over 31%, according to the DRC’s health ministry.

‘Record time’

The PARTNERS trial will assess whether the antivirals, a monoclonal antibody called MBP134 and remdesivir, can improve the outcome and survival rate of people with Ebola in Bundibugyo. It will also evaluate whether combining the two antivirals provides additional benefits.

The WHO-sponsored trial is being coordinated by the DRC’s Institut National pour la Recherche Biomédicale (INRB), the Institute of Tropical Medicine in Belgium, and the University of Oxford in the United Kingdom.  

These two treatments were selected by the WHO Technical Advisory Group “after a thorough review of scientific evidence, including preclinical research and safety data, and evidence from previous outbreak responses”, said the WHO in a statement. 

It is a randomised, controlled trial that is enrolling patients of any age with confirmed Bundibugyo. Aside from the medicine, patients will receive “early supportive care, including oral or intravenous fluids, electrolyte replacement, oxygen support, blood pressure management, and pain control in line with WHO treatment guidelines”, according to the WHO.      

People enrolled in the trial will receive “close support and follow-up for at least 28 days after enrolment,” it added.

Tedros said that the trial had been assembled “in record time, [and] offers real hope that we can deliver concrete results for – and with – the communities at the heart of the outbreak.”

The trial has been established as a platform trial, which allows for additional treatments to be added as they become available following assessment by the WHO Technical Advisory Group.

Dr Vasee Moorthy, WHO R&D Blueprint lead.

INRB Director General Prof Jean-Jacques Muyembe-Tamfum, said that, “by integrating this trial into clinical care, we are giving patients access to promising investigational treatments while generating the evidence needed to improve care for current and future outbreaks. “

“One of the key lessons from recent outbreaks is that research needs to happen alongside the response, not after it,” said Professor Amanda Rojek, the trial lead from Oxford University’s Pandemic Sciences Institute. 

“The PARTNERS trial gives us an opportunity to evaluate potential treatments during the outbreak itself, so that the evidence generated can help inform patient care when it is needed most – in months rather than years,” said Rojek.

DRC Health Minister Samuel Kamba said that the trial demonstrated his country’s “strong commitment to science and research,” and it offered “renewed hope to patients, their families, and affected communities”. 

The trial will conclude once an independent data safety monitoring committee is confident about the results, said WHO R&D Blueprint lead Dr Vasee Moorthy.

“From what we see at the moment, this is going to take some time,” said Moorthy. “We shouldn’t expect that this is going to be over in weeks. It will take some months. It could go even into next year. It could be that we need over 1000 patients enrolled in the trial until we get a definitive answer or it could be earlier if there’s a very high efficacy from the trial.”

Moorthy added that “discussions with the community as absolutely central, because all this is about protecting the community”. 

The trial has “community advisory panels with representatives from all of the relevant trusted stakeholder groups on the ground, including healthcare workers, community leaders, faith groups, and other leaders”, he added.

Image Credits: DRC Ministry of Health.

Malaria is becoming more frequent in parts of India as the climate changes, taking a heavy toll on those involved in agricultural activities.

In 1994, Manvati Nag, an indigenous woman from Bijapur district in the central Indian state of Chhattisgarh, married and moved to Halbaras village in the forested Dantewada region about 80 kilometres away.  Although the move was relatively short, it dramatically altered her health.

Before moving, Nag never got sick. But after her move, she started to get malaria “once every year or two”, she told Dialogue Earth. And since 2022, she has contracted malaria “almost every three months, whether it is summer, monsoon or winter”.

Nag’s experience reflects a larger shift unfolding across India’s hilly and forested regions, where climate change is altering the geography of disease.

The shift comes amid rapidly changing climatic conditions across the country. According to several climate assessments, 2024 was one of India’s most extreme weather years in decades, marked by record-breaking heatwaves, floods, storms and prolonged periods of unusual heat.

Extreme weather events killed more than 3,200 people, damaged crops across millions of hectares and destroyed thousands of homes.

The following year, 2025, witnessed similar patterns, with floods affecting several parts of the country, followed by prolonged heatwaves and worsening air pollution. 

This year, a powerful storm in India’s Uttar Pradesh state killed 117 people. More broadly, climate disasters and extreme weather events have disrupted the lives of millions across the country.

Heat exposure alone caused India to lose an estimated 160 billion labour hours in 2021, equivalent to around 5.4% of the country’s GDP. Studies have also estimated that India could lose nearly 2% of its GDP annually due to health losses linked to air pollution.

But beyond the visible economic and environmental damage, scientists and public health experts warn that something deeper is unfolding: climate change is steadily reshaping disease patterns across the country.

Rising temperatures in Kashmir and Himachal

The temperature in Srinagar, a city in Indian-administered Kashmir, is rising and its winters are getting shorter.

Indian-administered Kashmir, located in northern India, is a valley surrounded by mountains and long known for its alpine landscapes, world-class skiing, cold winters and clean waterways. 

The region, part of the larger Jammu and Kashmir territory, historically experienced mild summers, with temperatures usually remaining between 25°C and 27°C. Winters regularly dipped below freezing, often bringing heavy snowfall across the valley and surrounding mountains.

Much of the region’s climate has traditionally been shaped by its geography. Southern and southwestern parts of Jammu and Kashmir experience a subtropical climate with hot summers and cool winters, receiving most of their rainfall during the monsoon season. 

In the Kashmir Valley and higher-altitude mountain regions, however, the influence of the monsoon has historically been weaker, with much of the precipitation arriving during spring and winter months.

But in recent years, these long-established weather patterns have begun to change rapidly, residents and climate scientists say.

Intense heat

Aneeqa Wani, 21, a resident of Srinagar in Kashmir, told Health Policy Watch that she was shocked by the intense heat recently,  struggling to sleep for several days.

“For the first time, I had to switch on both the air conditioner and the fan just to sleep,” she said. “It is getting hotter day by day. Even this winter did not feel very long. We saw snowfall mostly in late February and March, but the rest of the season felt relatively dry.”

Wani said the changes feel especially noticeable compared with previous years.

“I still remember around 2017 or 2018, winters and snowfall would usually begin around November and continue till April,” she said.

Recent weather data reflects those changes. Earlier this year, Kashmir recorded unusually high winter temperatures, with February temperatures rising nearly 10°C above normal and touching 21°C in some areas.

During a session of the Jammu and Kashmir Legislative Assembly in February, the government disclosed that the region had recorded a nearly 50% deficit in winter precipitation for the second consecutive year.

The warming trend has become increasingly visible in recent summers as well. In 2024, Kashmir recorded temperatures hotter than several major Indian cities, including Delhi and Kolkata. Srinagar recorded a maximum temperature of 35.7°C — six degrees above normal and the city’s highest July temperature in nearly 25 years, according to local meteorological officials.

Similar climatic shifts are also being observed in neighbouring Himachal Pradesh. In 2024 alone, the state experienced 28 heatwave days between April and June. During the same three-month period, Himachal Pradesh recorded nearly 2,700 forest fires, the highest number since 2007, according to reporting by Down To Earth.

Climate change and disease 

As the climate heats up, there has been a sharp rise in mosquito-borne diseases of malaria, dengue and chikungunya.

Vector-borne diseases were historically concentrated largely in India’s warmer tropical and subtropical regions, particularly across the plains and densely populated urban centres such as Delhi and parts of central India. But that pattern is now beginning to change.

Although India has made significant progress in reducing overall malaria transmission and deaths, the disease has still claimed more than 10,000 lives across the country over the last two decades, highlighting the continuing public health burden posed by climate-sensitive diseases.

The impact is not only measured in deaths and illness, but also in economic losses. Aedes-borne mosquito diseases alone are estimated to cause an average annual global economic burden of nearly $1.2 billion through healthcare costs, lost productivity and wider social disruption.

Public health experts say the diseases are once again drawing attention in India because their geographic spread is changing rapidly, particularly across mountainous and high-altitude regions that historically recorded far fewer cases.

According to India’s National Center for Vector-Borne Disease Control, Jammu and Kashmir recorded 3,381 dengue cases in 2025  nearly double the 1,709 cases reported in 2021.

Cases of chikungunya have also risen sharply across several hill states in recent years. Jammu and Kashmir reported 773 suspected chikungunya cases in 2025, up from just seven in 2021. Himachal Pradesh, which recorded no cases in 2021, reported more than 200 cases in 2025, while Meghalaya and Uttarakhand also registered significant increases.

Pallavi Joshi, area convenor for environment and public health at the Institute for Global Environmental Strategies, said a major factor behind the changing outbreak patterns is the shrinking gap between daytime and nighttime temperatures.

“Earlier, there was a significant difference between day and night temperatures, but that gap is shrinking,” Joshi told Health Policy Watch. “Temperatures now remain relatively stable over the 24-hour cycle, creating more favourable conditions for disease vectors to survive and spread, especially in hilly areas.”

Raghu Murtugudde, an environmental scientist, visiting professor at the Indian Institute of Technology (IIT) Bombay and emeritus professor at the University of Maryland, said warming temperatures are rapidly reshaping disease ecology across mountain regions.

“In hilly areas, diseases like malaria and chikungunya were historically uncommon because frost during winters would naturally limit transmission cycles,” Murtugudde told Health Policy Watch.

“But winters are becoming warmer, humidity levels are rising, and vegetation patterns are changing. These conditions are allowing diseases to persist and spread in regions where they were previously uncommon.”

Gaps in surveillance and climate preparedness

Urvashi Prasad, former director at the Indian government think tank NITI Aayog, said climate change is disrupting the traditional seasonal patterns of vector-borne diseases in India.

“Earlier, outbreaks were largely associated with the rainy season, but that replication cycle has now extended beyond it,” Prasad told Health Policy Watch. “We are now seeing rainfall at unusual times, rising temperatures across seasons and longer periods of heat, all of which are affecting the geography, timing and duration of outbreaks.”

Prasad said one of the biggest challenges is that climate data remains poorly integrated into India’s disease surveillance systems.

“When outbreaks occur in hilly or remote regions, they are often detected too late,” she said. “By the time cases are officially reported, and response mechanisms begin, the outbreak has already spread further and lasted longer.”

She added that much of India’s current disease tracking remains reactive rather than predictive.

“Most interventions begin only after outbreaks occur,” she said. “Climate intelligence is still not being properly used to anticipate disease hotspots or forecast outbreaks before they escalate.”

According to Prasad, India urgently needs stronger integration between climate and public health data systems, including the use of satellite rainfall data, temperature trends and environmental indicators to identify emerging risks in advance.

“We usually realise the scale of a serious outbreak only after it appears in the news and then authorities react,” she said. “It should not happen like this. We need early warning systems that can predict hotspots before outbreaks spread.”

She also stressed the need for stronger coordination between climate agencies, health departments and disaster-management authorities, arguing that institutional fragmentation remains a major obstacle.

“There is very little real coordination between departments in practice,” she said. “You can pick almost any issue in India and find the same problem — coordination exists mostly on paper.”

Prasad noted that even institutions created to facilitate inter-ministerial coordination often struggle to enforce cooperation.

“NITI Aayog itself was created partly to improve coordination across sectors, but even ministries sometimes resist working together,” she said. “We need a stronger institutional anchor that can coordinate, monitor and ensure departments actually work together on climate and health risks.”

Air pollution crisis

Air pollution is a growing problem in Kashmir, with a sharp rise in vehicle emissions which gets trapped in the valley.

While climate-linked disease risks are rising, Kashmir is also facing another growing public health challenge: worsening air pollution.

“In recent years, especially after COVID-19, Kashmir has been struggling to breathe the fresh air we once used to,” said Arshid Khan, 32, a resident of Ikhrajpora in Srinagar.

Khan told Health Policy Watch that after 2020, tourism surged in Kashmir as COVID-19 restrictions eased across the country. While the tourism boom brought economic opportunities, it also triggered an explosion in the number of vehicles on Kashmir’s roads.

“Tourism was good for the economy, but most people here are unemployed and trying to survive,” he said. “People felt there were only two ways to earn from tourism — either open a hotel, which not everyone can afford, or buy a cab.”

According to Khan, thousands of families invested heavily in tourist taxis after the pandemic, leading to a sharp rise in vehicle registrations across the valley.

“People were so desperate that for cars costing seven or eight lakh rupees, buyers would even pay companies an extra one lakh just to get delivery faster,” he said. “Now it feels like Kashmir is slowly becoming like Delhi.”

The growing traffic burden has coincided with worsening air quality in Srinagar. Earlier this year, Bhaskar English reported that air pollution levels in Srinagar had reached their worst levels in seven years. The city’s average PM2.5 concentration was reported at 115 micrograms per cubic metre — far above the limits recommended by the World Health Organization (WHO).

Health experts warn that long-term exposure to pollution at those levels carries serious health risks, including respiratory and cardiovascular diseases. According to recent air-quality assessments, 2026 has so far been Srinagar’s most polluted year since 2019, with an average Air Quality Index (AQI) of 159.

Director of Sher-i-Kashmir Institute of Medical Sciences (SKIMS), Dr Parvaiz Koul said in a recent interview with Mongabay that around 10,000 people die in Jammu and Kashmir every year due to diseases attributable to air pollution 

For many residents, the crisis reflects a broader transformation unfolding across the Himalayan region — where climate change, rapid urbanisation, rising pollution and shifting disease patterns are beginning to converge into a growing public health emergency.

Image Credits: EqualStock IN/Pexels, Syed Qaarif Andrabi , Commons Wikimedia, Rutpratheep Nilpechr/ Unsplash.

Marburg containment
Health workers contain the highly fatal Marburg virus during an outbreak.

An outbreak of Marburg, a highly infectious haemorrhagic fever, has been reported in western Uganda.

The outbreak was discovered after a child died, according to Reuters, while Stat reports that two cases of Marburg were reported to the World Health Organization (WHO) this week.

Uganda is already trying to contain an outbreak of Ebola Bundibugyo Virus, which is also a viral haemorrhagic fever.

The US Embassy in Uganda noted reports of Marburg on Monday and urged caution. The US issued a level four “do not travel” alert for Uganda on 4 June, citing “crime, health, terrorism, and unrest”. This came in the wake of the declaration of Ebola Bundibugyo as a public health of international concern by the WHO on 17 May.

The Africa Centres for Disease Control and Prevention confirmed the Marburg outbreak, which Uganda is obliged to report in terms of the International Health Regulations, in  Kyegegwa district involving an 18-month-old child who had died.

Meanwhile, Uganda has reported 20 cases of Ebola Bundibugyo, the majority from the outbreak in the Democratic Republic of Congo (DRC).

While Africa CDC said that all the country’s Ebola cases stem from the DRC, a local newspaper, Monitor, reports that five of the cases involved local transmission.

Marburg is usually transmitted from animals to humans, with Egyptian Rousettus bats being a key carrier of the virus.

Image Credits: WHO.

Climate change is one of the WHO’s top six health priorities, but there are few funds to address it.

On the day France recorded its hottest temperature on record, a coalition of health ministers, officials and advocates huddled in a sweaty, half-full auditorium in Paris to take stock of a campaign they have spent a decade waging: the fight to put human health at the centre of the world’s response to climate change.

The meeting was a high-level gathering of the Alliance for Transformative Action on Climate and Health (ATACH), the WHO-hosted network of 106 countries launched at COP26 in Glasgow in 2021. 

Convened under France’s G7 presidency, the summit’s task was to look ahead to COP31 in Antalya in Türkiye in November, to gauge what fights the health community should place at the top of its agenda. 

For a movement that began with a handful of officials struggling to be heard, ATACH has grown almost faster than it can handle. “We’ve accidentally been too successful,” said Nick Watts, director of the Centre for Sustainable Medicine at the National University of Singapore, who has tracked the alliance since its creation.

While part of the meeting carried the air of a victory lap, it was also a reckoning with the one thing recognition has not delivered: money.

“Finance is the weakest one, and I think this is a key point for this meeting,” said Elena Villalobos Prats, the WHO official who built much of ATACH’s architecture.

“It’s not just a plea for external support to come to countries,” Prats added. “It’s really about making sure that ministries of health, that now understand what the problem is, have the capacity and the resources to do something about it.”

Winning recognition

Dubai’s COP28 produced the first health and climate declaration.

ATACH was itself a creation of UN climate talks, among the first concrete health commitments to come out of the climate COP process when it launched in Glasgow in 2021. The milestones – in terms of words on paper, if not finance – have piled up from there.

Dubai’s COP28 produced a health declaration signed by more than 140 countries, unveiled at an event thick with fanfare and celebrity guests like Bill Gates. The following year, in a windowless room in the underground levels of Baku’s football stadium, COP29 created a coalition that committed future presidencies to keep health on the agenda, securing a formal recognition health leaders had sought for over two decades.  

Then COP30 in Brazil delivered the Belém Health Action Plan, a voluntary framework of 60 measures to ready health systems for climate shocks, and the clearest sign yet that health had secured a permanent place on the UN climate agenda.

“I think we don’t need to tell everyone anymore. I think this is very clear,” said Agnes Soares da Silva of Brazil’s Ministry of Health, who helped write the Belém plan. Real-world action, however, “has not been at the same level”, she added. 

The health community has hailed each declaration and framework as a breakthrough. Yet none is binding, all are voluntary, and none sits inside the formal UN negotiations where targets are set, international legal obligations are made, and money is committed.

And the money required is astronomical. The World Bank estimates climate change could cause up to 15.6 million additional deaths between 2026 and 2050 and inflict $8.6 trillion to $15.4 trillion in health costs by mid-century. WHO calls it “the greatest single risk to humanity.”

“Even if we stop our emissions now, we still need to adapt,” Soares da Silva said. WHO’s director-general had made the same point in reverse. “We must adapt our health systems,” Dr Tedros Adhanom Ghebreyesus said, “but we must also mitigate the cause of climate change by drastically reducing emissions, including from the health sector.”

With the fight for attention successfully won, the hard part begins – getting into the rooms that can fund the response to the worsening climate-health crisis. 

The evidence is settled

12 of 20 climate-health indicators are now at catastrophic levels, including a sharp rise in heat-related deaths globally.
Twelve of 20 climate-health indicators are now at catastrophic levels, including a sharp rise in heat-related deaths globally.

The science underpinning the campaign is no longer seriously contested. Diarmid Campbell-Lendrum, who leads WHO’s climate and health work, told the room that extreme heat “kills over half a million people each year,” and that researchers had seen that coming for many years. 

“We told you so,” he said, relaying the message of the scientists who first described the greenhouse effect two centuries ago.

That figure comes from the latest Lancet Countdown, which counted around 546,000 heat deaths a year, roughly one a minute, alongside 2.52 million deaths from air pollution caused by burning fossil fuels. Thirteen of its 20 health indicators stood at record highs.

Those effects reach further than hospitals and heatwaves, down to the chemistry of the medicines themselves. Vincent Breton of Unitaid traced the climate exposure of a single product, the HIV treatment taken by 24 million people. In a Kenyan clinic, he said, women were swallowing their pills every day yet still showing high viral loads, because they had been storing the medicine in the kitchen, the hottest room in the house, where it degrades in the heat.

“Climate crisis is a health crisis, not hypothetically in the future, but here and now,” WHO Director-General Tedros Adhanom Ghebreyesus told the meeting by video, kept away by an Ebola outbreak in the Democratic Republic of Congo. 

“Responding to climate change is a key strategic objective for WHO, and ATACH is our most powerful tool to take action against this existential threat.”

EU climate monitor Copernicus maps highlight severe extreme weather and heatwaves across Europe in May 2026.
EU climate monitor Copernicus maps highlight severe extreme weather and heatwaves across Europe in late May 2026 – even before June’s severe heatwave commenced.

There have been over 1,300 excess deaths since the start of the record-breaking heatwave in Europe on 21 June, according to Tedros.

WHO now ranks climate change as the first of six priorities in its current programme of work, and its officials insist the economics are settled too. “At an absolute minimum, every dollar that you invest gets you $4 back,” Campbell-Lendrum said.

The economics also run the other way. The ingredients of that same HIV treatment trace back to oil, some of it routed through the Strait of Hormuz, leaving the medicine’s price exposed to crude markets and to what Breton called “the current geopolitical context.” 

In a study his team will soon publish, every 10% rise in the oil price translated into a 3% rise in the drug’s price. “How do you avoid being exposed to this risk?” he asked. “Simple answer: decarbonization.”

A movement wide but shallow

COP30 in Brazil’s Belém adopted a health plan, a voluntary framework of 60 measures that countries can adopt to prepare for climate shocks.

ATACH currently counts 106 member countries, more than half the nations that turn up to the climate talks, but membership demands little and delivers less.

Joining requires little more than a statement of intent. Endorsing the Belém plan, the concrete commitment the alliance now wants implemented, takes a signature, and fewer than three dozen countries have so far provided one.

Completing the work the plan describes is rarer still. As of last year, only three members, France, Japan and the United Kingdom, had completed all four assessments that ATACH asks of them. 

There is no penalty for members that do nothing, and, as Health Policy Watch reported from Baku, no mechanism to verify whether commitments translate into action on the ground.

Watts, presenting a new ATACH strategy for 2026 to 2028, was blunt about the habit of the alliance’s members of substituting documents for delivery.

“I have read the same five-page policy brief on climate change and health genuinely, maybe 1000 times,” he said. “They’ve said the same thing for the last two decades. Let’s move on.”

The new strategy leans on regional hubs, a modest catalyst fund and what the alliance calls “implementation clinics,” all meant to drag members from writing plans toward building things.

Another COP, another building block

Installing solar power in primary health centres in Karnataka state in India is making healthcare services safer and more reliable.

Türkiye, which holds the COP31 presidency, used the meeting to lay out what it wants from Antalya. Rather than a departure from the pattern, it plans to attach health more firmly to the summit’s action agenda, the voluntary track that runs alongside the negotiations proper.

“We aim to focus on designing the healthcare system we need by adding a new building block to the Belem action plan,” a senior official from Türkiye’s health ministry told the meeting. 

That building block, published as a COP31 priority titled “Dynamic and Resilient Health Systems,” runs to seven goals spanning resilient infrastructure, disease surveillance, early-warning systems, artificial intelligence, a trained workforce, cross-sector coordination and “sustainable financing.” It sets no targets, attaches no figures, fixes no timeline and names no mechanism to deliver any of it.

The priorities largely restate the pillars of the Belém plan, which in turn restated the Baku and Dubai declarations before it. The proposal to build further on Belém also sits uneasily against the plan’s thin support, given that most ATACH members have yet to endorse the document it would extend.

As Türkiye and Australia’s joint presidency angle to strategically side-step the issue of fossil fuels that torpedoed the previous two COPs in Belém and Baku, the COP31 health priority – like the Belém plan it is building on – makes no mention of the role of fossil fuels in the climate crisis. 

“If we don’t have the personnel, and if we don’t have the funds, then it’s just a paper that may be sitting on the shelves,” Zimbabwean Health Minister Douglas Mombeshora, told the meeting. 

Still no money

The WHO-led high-level ministerial meeting on climate and health at COP29 in Baku took place in a cramped, windowless meeting room- reflecting the longtime struggle delegates have faced to win wider recognition of the linkages in the climate arena.

The French Development Agency puts the cost of adapting the world’s health systems to climate change at $22 billion. The UN climate body’s estimate runs higher, at $26.8 billion to $29.4 billion a year by 2050.

At COP29, in Baku, wealthy nations agreed to provide $300 billion a year by 2035, against the $1.3 trillion the developing world said it needed. Health receives a fraction of a fraction of that, capturing roughly 2% of adaptation funding and 0.5% of multilateral climate finance, a share that has not moved since Glasgow.

The collapse of aid budgets, led by the United States, has tightened the squeeze. “The world just feels a little bit meaner,” Watts said. “We’re entering into a bit of a rough patch. It’s going to last for a couple of years, and everyone knows what it feels like in their own national context.”

The only fresh money announced at COP30 came from philanthropy, with a $300 million commitment from the Gates Foundation, Wellcome and the Rockefeller Foundation. None has been added since.

“That is a drop in the ocean,” said Arthy Hartwell of the Wellcome Trust, an anchor of the funders’ coalition. 

Part of the trouble, she said, is that health falls between two budgets. “We’re either talking about climate finance or we’re talking about health finance, and actually that ambiguity slows everything down.”

Campbell-Lendrum was blunt that the failure is one of will rather than knowledge. “We’re coming up with a plan, we’re still not investing, or not investing enough,” he said. “If anything, it’s got worse; we’re not prioritising this around the world.”

Tamer Samah Rabie of the World Bank located the deeper problem in chronically starved health budgets: “Low- and middle-income countries pay about $8 per person per year on a basic package of services, when in fact they should have been spending about 60 to $80 per person per year.” 

The total cost of carrying on at this level of underinvestment would reach “$21 trillion” by 2050, Rabie said. 

“Let’s stop talking about putting together another report, another plan for how we bring in more sources of finance,” he said. “Let’s be a lot more operational.”

The fund WHO just unlocked

Green Climate Fund Director Dr Oyun Sanjaasuren.

In March, WHO became an accredited entity of the Green Climate Fund, the world’s largest climate fund, having already been approved as an implementing entity of the smaller Adaptation Fund.

The status lets WHO write and manage health funding proposals directly, rather than merely helping countries apply for small preparatory grants. Accreditation is a licence to compete for funding – and so far, health has been virtually absent from the GCF portfolio.

As of COP29, the Green Climate Fund had financed a single health project, in Malawi, and Health Policy Watch reported at the time that the country’s own climate minister did not know it existed.

The fund was designed to let developing-country institutions draw cash down directly, yet the bar has proved too high for most. Of 62 national entities accredited for direct access, 42 have never received any funding from GCF, and only about a fifth of approved projects flow through them. The rest is routed through international bodies such as the World Bank and the UN.

“We absolutely need to simplify access to finance, and for me it remains a major barrier, because the financing landscape still is really complex, really fragmented,” said Camille Perron, deputy head of the Health and Social Protection Division at the French Development Agency. 

Co-financing a single climate and health project through the agency, he added, “sometimes takes from two to sometimes three years to land on the project preparations and be able to commit an investment to our board.”

WHO’s new role does nothing to lower that bar for health ministries, but does add a potential ally in another international middleman, even as WHO contends with an existential budget crisis of its own.

The WHO’s new status will not unlock enough money to shift the needle on the climate crisis, but it can help individual communities. Yet the difficulty of the bureaucracy of the fund means even that may take time. 

An analysis of the fund’s first five years found that projects for the poorest countries took 20 to 22 months on average just to win approval, with the slowest taking nearly five, and that least-developed countries had received less than 9% of the money approved for them after more than five years. 

The Adaptation Fund, with a single-country cap of $25 million and roughly $1.6 billion committed since 2010, deals in sums that electrify a clinic or buy a cold-chain freezer, not money that rebuilds a health system.

“It’s wonderful that WHO are now implementing partners for the GCF. This is what is needed, the technical capacity and expertise,” Wellcome’s Artwell said. “The scale of the challenge isn’t enough for just philanthropy to try and do.”

 

Image Credits: WMO, Felix Sassmannshausen, EU/Copernicus, X/@Cop30noBrasil, Selco Foundation.

Robert F Kennedy Jr

US Health Secretary Robert F Kennedy Jr has broadened the terms of the country’s vaccine advisory committee in an apparent move to circumvent a judge’s ruling that his appointees lacked the requisite experience to serve as the country’s immunisation advisors.

The new charter for the Advisory Committee on Immunization Practices (ACIP) was published on the Centers for Disease Control and Prevention’s (CDC) website last week.

Instead of requiring vaccine-related expertise, the new terms simply require that “members shall collectively represent a balanced range of scientific, clinical, and public health expertise relevant to the committee’s mission”. 

A day earlier, US Senator Bernie Sanders released 253 pages of emails showing how Kennedy’s Health and Human Services (HHS) staff pressured CDC officials to influence the country’s vaccine policies. ACIP advises the CDC on vaccines.

One of the emails from Matthew Buckham, Kennedy’s chief of staff (19 August 2025), to then CDC Director Susan Monarez stated “the absolute need for political review of major decisions at CDC”.

Email from HHS Chief of Staff Matthew Buckham to then CDC Director Susan Monarez (19 August 2025).

An email from CDC staffer Nicole Coffin (14 February 2025) reveals that HHS communications director Andrew Nixon “asked that we pull out of circulation all campaign ad buys related to flu or anything encouraging shots or vaccinations. He said this request came directly from the secretary.” 

An email from CDC staffer Nicole Coffin (14 February 2025) reveals that HHS communications director Andrew Nixon

The emails also reveal Kennedy’s influence over ACIP, including his removal of members without the required consultation with the CDC and his control over the committee’s agenda, particularly to review hepatitis B and multi-dose flu vaccines for pregnant women and children, the reintroduction of a seven-year review and biannual report on vaccines, and review of the definition of vaccines (19 May 2025).

Email from HHS to CDC (19 May 2026)

In March, US District Judge Brian Murphy ruled that the January changes to the vaccination schedule and Kennedy’s firing of all 17 ACIP members are likely to have violated the Administrative Procedure Act. 

Murphy also issued three temporary stays: on Kennedy’s appointment of 13 new ACIP members, mostly vaccine sceptics; changes to the vaccination schedule, and all decisions of the Kennedy-appointed ACIP. These stays will be in place until Murphy can rule on a lawsuit brought by the American Academy of Pediatrics (AAP) and other medical organisations against Kennedy’s “unilateral changes” to vaccinations for children and pregnant women.

Tighter control over science

Meanwhile, the Trump administration also plans to further tighten its control over scientific grants, placing them under the control of politicians and their appointees.

The proposed changes to US government support for scientific research is being pushed by the White House Office of Management and Budget (OMB), which is headed by former Heritage Foundation leader Russell Vought.

According to the proposed rule change, politicians and their appointees will be able to decide on funding without the advice of scientists, stop it at will and limit or prevent partnerships with other countries.

In a note explaining the proposed change, the OMB claims that “far-left activists hijacked the critical work done by the US President’s Emergency Plan for AIDS Relief (PEPFAR), which was established to respond to the AIDS crisis in Africa. Due to wasteful spending, PEPFAR became a left-wing foreign aid entitlement that attempted to promote abortion and gender ideology”. 

However, the editors of the New England Journal of Medicine noted in a recent editorial: “Giving political appointees ultimate authority to determine federal grant funding, as proposed by the OMB, would politicise and weaken biomedical research.

“Expert, independent peer review of grant applications is essential for directing NIH dollars to research that has the greatest potential for advancing science and improving health. Selecting the most promising research is an enormously complex and challenging undertaking, but over the past 70 years, scientific advances achieved with rigorous methods in clinical trials have improved quality of life, transformed human health, and extended life expectancies.”

The proposal is open for public comment until 13 July, and the OMB intends to issue a final rule by 1 October.

Image Credits: HHS.